Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Regulatory Forum Review*: Utility of in Vitro Secondary Pharmacology Data to Assess Risk of Drug-induced Valvular Heart Disease in Humans: Regulatory Considerations.

Papoian T, Jagadeesh G, Saulnier M, Simpson N, Ravindran A, Yang B, Laniyonu AA, Khan I, Szarfman A.

Toxicol Pathol. 2017 Apr;45(3):381-388. doi: 10.1177/0192623317690609. Epub 2017 Jan 1. Review.

PMID:
28421966
2.

Secondary pharmacology data to assess potential off-target activity of new drugs: a regulatory perspective.

Papoian T, Chiu HJ, Elayan I, Jagadeesh G, Khan I, Laniyonu AA, Li CX, Saulnier M, Simpson N, Yang B.

Nat Rev Drug Discov. 2015 Apr;14(4):294. doi: 10.1038/nrd3845-c1. Epub 2015 Mar 20. No abstract available.

PMID:
25792260
3.

Endotoxin-induced microvascular leakage is prevented by a PAF antagonist and NO synthase inhibitor.

Laniyonu AA, Coston AF, Klabunde RE.

Shock. 1997 Jan;7(1):49-54.

PMID:
8989836
5.

Tyrosine kinase inhibitors and the contractile action of G-protein-linked vascular agonists.

Laniyonu AA, Saifeddine M, Yang SG, Hollenberg MD.

Can J Physiol Pharmacol. 1994 Sep;72(9):1075-85.

PMID:
7842390
7.
8.
9.

Interaction by bendrofluazide with acetylsalicylic acid.

Oyekan AO, Laniyonu AA.

Gen Pharmacol. 1986;17(2):251-4.

PMID:
3699451
11.
12.
13.

Interaction between frusemide and aspirin.

Oyekan AO, Laniyonu AA, Ashorobi RB.

Gen Pharmacol. 1984;15(2):163-6.

PMID:
6714643

Supplemental Content

Loading ...
Support Center